Tilray Shares Soar as CEO Touts Pot's Growth Potential
Tilray Shares Soar as CEO Touts Pot's Growth Potential
Sep.19 — Tilray Inc. shares set up for a third-straight day of gains after the company received clearance from the U.S. DEA to import medical marijuana to supply a clinical trial in California. Bloomberg Intelligence’s Ken Shea reports on “Bloomberg Daybreak: Americas.”
Tilray is the subpar quality bud light of the weed market.. long time users do not enjoy their product, we have talked about it for years here on youtube.. many canadian growers have a strong dislike for tilray and other corplrate subpar companies who use advertising and celebrities to sell product. They will never have A grade product as quality and quantity is seperated.. and tilray is all quantity indoor which is becoming overpriced compared to outdoor quality from small farms with a true passion